DK1964570T3 - Farmaceutisk sammensætning til beskyttelse mod allergier og inflammatoriske sygdomme - Google Patents

Farmaceutisk sammensætning til beskyttelse mod allergier og inflammatoriske sygdomme

Info

Publication number
DK1964570T3
DK1964570T3 DK07004329.4T DK07004329T DK1964570T3 DK 1964570 T3 DK1964570 T3 DK 1964570T3 DK 07004329 T DK07004329 T DK 07004329T DK 1964570 T3 DK1964570 T3 DK 1964570T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical composition
protection against
inflammatory diseases
against allergies
allergies
Prior art date
Application number
DK07004329.4T
Other languages
English (en)
Inventor
Johann Bauer
Nicole Bluemer
Albrecht Bufe
Jennifer Debarry
Markus Ege
Susanne Friedrich
Holger Garn
Soeren Gatermann
Anna Hanuszkiewicz
Holger Heine
Otto Holst
Harald Renz
Mutius Erika Von
Michael Wegmann
Original Assignee
Protectimmun Gmbh
Forschungszentrum Borstel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Protectimmun Gmbh, Forschungszentrum Borstel filed Critical Protectimmun Gmbh
Application granted granted Critical
Publication of DK1964570T3 publication Critical patent/DK1964570T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK07004329.4T 2007-03-02 2007-03-02 Farmaceutisk sammensætning til beskyttelse mod allergier og inflammatoriske sygdomme DK1964570T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07004329A EP1964570B1 (de) 2007-03-02 2007-03-02 Pharmazeutische Zusammensetzung zum Schutz vor Allergien und entzündlichen Erkrankungen

Publications (1)

Publication Number Publication Date
DK1964570T3 true DK1964570T3 (da) 2012-12-17

Family

ID=38420621

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07004329.4T DK1964570T3 (da) 2007-03-02 2007-03-02 Farmaceutisk sammensætning til beskyttelse mod allergier og inflammatoriske sygdomme

Country Status (4)

Country Link
US (1) US9950017B2 (da)
EP (1) EP1964570B1 (da)
DK (1) DK1964570T3 (da)
ES (1) ES2399993T3 (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
ES2399993T3 (es) 2007-03-02 2013-04-04 Protectimmun Gmbh Composición farmacéutica para la protección frente a alergias y enfermedades inflamatorias
WO2010020379A1 (en) * 2008-08-16 2010-02-25 Protectimmun Gmbh Composition for prevention and treatment of allergic and/or inflammatory diseases
BR112012003706A2 (pt) * 2009-08-18 2015-09-01 Nestec Sa Composição nutritiva que compreende cepas de lactococcus e reduz sintomas de alergia, especialmente em bebês e crianças
US9457077B2 (en) 2009-11-18 2016-10-04 Katherine Rose Kovarik Method and system for targeting the microbiome to promote health and treat allergic and inflammatory diseases
US9585920B2 (en) 2011-02-04 2017-03-07 Katherine Rose Kovarik Method and system for treating cancer cachexia
US9408880B2 (en) 2013-12-20 2016-08-09 Katherine Rose Kovarik Method and system for prevention and treatment of allergic and inflammatory diseases
EP2361632B1 (en) 2010-02-19 2014-03-19 Protectimmun GmbH Specific environmental bacteria for the protection from and/or the treatment of allergic, chronic inflammatory and/or autoimmune diseases
WO2011151941A1 (ja) 2010-06-04 2011-12-08 国立大学法人東京大学 制御性ｔ細胞の増殖または集積を誘導する作用を有する組成物
US9730967B2 (en) 2011-02-04 2017-08-15 Katherine Rose Kovarik Method and system for treating cancer cachexia
US10245288B2 (en) 2011-02-04 2019-04-02 Joseph E. Kovarik Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease
US11951139B2 (en) 2015-11-30 2024-04-09 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US11951140B2 (en) 2011-02-04 2024-04-09 Seed Health, Inc. Modulation of an individual's gut microbiome to address osteoporosis and bone disease
US11357722B2 (en) 2011-02-04 2022-06-14 Seed Health, Inc. Method and system for preventing sore throat in humans
US11191665B2 (en) 2011-02-04 2021-12-07 Joseph E. Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US10085938B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for preventing sore throat in humans
US11844720B2 (en) 2011-02-04 2023-12-19 Seed Health, Inc. Method and system to reduce the likelihood of dental caries and halitosis
US10835560B2 (en) 2013-12-20 2020-11-17 Joseph E. Kovarik Reducing the likelihood of skin cancer in an individual human being
US9987224B2 (en) 2011-02-04 2018-06-05 Joseph E. Kovarik Method and system for preventing migraine headaches, cluster headaches and dizziness
US10111913B2 (en) 2011-02-04 2018-10-30 Joseph E. Kovarik Method of reducing the likelihood of skin cancer in an individual human being
US10687975B2 (en) 2011-02-04 2020-06-23 Joseph E. Kovarik Method and system to facilitate the growth of desired bacteria in a human's mouth
US10548761B2 (en) 2011-02-04 2020-02-04 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US11523934B2 (en) 2011-02-04 2022-12-13 Seed Health, Inc. Method and system to facilitate the growth of desired bacteria in a human's mouth
US11419903B2 (en) 2015-11-30 2022-08-23 Seed Health, Inc. Method and system for reducing the likelihood of osteoporosis
US10314865B2 (en) 2011-02-04 2019-06-11 Katherine Rose Kovarik Method and system for treating cancer and other age-related diseases by extending the healthspan of a human
US10010568B2 (en) 2011-02-04 2018-07-03 Katherine Rose Kovarik Method and system for reducing the likelihood of a spirochetes infection in a human being
US10512661B2 (en) 2011-02-04 2019-12-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
US11273187B2 (en) 2015-11-30 2022-03-15 Joseph E. Kovarik Method and system for reducing the likelihood of developing depression in an individual
US10086018B2 (en) 2011-02-04 2018-10-02 Joseph E. Kovarik Method and system for reducing the likelihood of colorectal cancer in a human being
US10583033B2 (en) 2011-02-04 2020-03-10 Katherine Rose Kovarik Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being
US10842834B2 (en) 2016-01-06 2020-11-24 Joseph E. Kovarik Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
JP2014528959A (ja) * 2011-10-03 2014-10-30 アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル Ｔｈ２介在性疾患の処置のための方法および薬学的組成物
WO2013080561A1 (en) 2011-12-01 2013-06-06 University Of Tokyo Human-derived bacteria that induce proliferation or accumulation of regulatory t cells
US11839632B2 (en) 2013-12-20 2023-12-12 Seed Health, Inc. Topical application of CRISPR-modified bacteria to treat acne vulgaris
US11980643B2 (en) 2013-12-20 2024-05-14 Seed Health, Inc. Method and system to modify an individual's gut-brain axis to provide neurocognitive protection
US11826388B2 (en) 2013-12-20 2023-11-28 Seed Health, Inc. Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation
US11833177B2 (en) 2013-12-20 2023-12-05 Seed Health, Inc. Probiotic to enhance an individual's skin microbiome
US11969445B2 (en) 2013-12-20 2024-04-30 Seed Health, Inc. Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH
KR101618330B1 (ko) 2015-03-27 2016-05-09 중앙대학교 산학협력단 락토코커스 중앙젠시스를 유효성분으로 함유하는 염증성 질환의 예방 또는 치료용 약학적 조성물
JP2020508357A (ja) * 2017-02-27 2020-03-19 コンティニュアム グループ エルエルシー 日焼け止め剤
US11883445B2 (en) 2018-03-14 2024-01-30 Emory University Lactococcus bacteria and uses thereof
CN117695374A (zh) * 2024-01-25 2024-03-15 超越健康科技(浙江)有限公司 一种用于治疗帕金森病的生物药物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS579722A (en) * 1980-06-20 1982-01-19 Teijin Ltd Immunologically active substance and its preparation
EP0178443B1 (en) * 1984-10-16 1992-06-10 Emulsan Biotechnologies Inc. Cosmetic and pharmaceutical compositions containing bioemulsifiers
WO1995031984A1 (en) 1994-05-20 1995-11-30 The Regents Of The University Of California Method and reagents for the treatment of rheumatoid arthritis
DE4422859C2 (de) 1994-06-30 2000-10-05 Laves Arzneimittel Gmbh Wäßrige Zellextrakte aus Mykobacterien
JPH107577A (ja) * 1996-06-17 1998-01-13 Yakult Honsha Co Ltd 血糖降下剤
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
GB9800487D0 (en) 1998-01-09 1998-03-04 Oratol Limited Therapies
JP2997774B1 (ja) * 1998-08-03 2000-01-11 農林水産省蚕糸・昆虫農業技術研究所長 動物及び植物病原菌由来毒素の解毒剤
EP1115408B1 (en) 1998-09-23 2006-01-25 Pfeinsmith Limited Oxihumic acid and its use in the treatment of various conditions
DE19963840A1 (de) 1999-12-30 2001-09-13 Erika Von Mutius Zusammensetzung zum Vorbeugen und Behandeln von allergischen Erkrankungen
DE10007771A1 (de) 2000-02-14 2001-08-23 Kleine & Steube Entoxin Gmbh Immunmodulatorisch wirksame Zusammensetzungen, Verfahren zu ihrer Herstellung und ihre Verwendung
KR100404236B1 (ko) 2000-05-17 2003-11-01 (주)바이오니아 비만 또는 당뇨병 치료용 미생물 및 상기 미생물을포함하는 의약 조성물
DE10101793A1 (de) 2001-01-17 2002-08-01 Manfred Nilius Verwendung von SLPI zur Behandlung chronisch-entzündlicher Darmerkrankungen
DE20202562U1 (de) * 2002-02-19 2002-05-23 Orthomol Pharmazeutische Vertr Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika
KR100518263B1 (ko) 2002-11-21 2005-10-04 학교법인 한마학원 락토코쿠스 락티스 ｎｋ24 (ｋｆｃｃ 11315) 생균을유효성분으로 함유하는 것을 특징으로 하는 위장병 예방및 치료용 조성물
EP1642932B1 (en) 2003-07-08 2012-03-21 Kaneka Corporation Curing composition
WO2005030230A1 (en) * 2003-09-30 2005-04-07 Probiomics Limited Compositions and methods for treatment or prevention of psoriasis and related disorders
JP4589618B2 (ja) 2003-11-28 2010-12-01 独立行政法人農業生物資源研究所 免疫調節性機能を誘導する乳酸菌類とその成分
US7601368B2 (en) 2004-09-01 2009-10-13 Lupin Limited Purified Arabinogalactan-Protein (AGP) composition useful in the treatment psoriasis and other disorders
ATE416776T1 (de) 2004-09-18 2008-12-15 Protectimmun Gmbh Stallstaub-extrakt zum schutz vor allergien
ES2399993T3 (es) 2007-03-02 2013-04-04 Protectimmun Gmbh Composición farmacéutica para la protección frente a alergias y enfermedades inflamatorias

Also Published As

Publication number Publication date
ES2399993T3 (es) 2013-04-04
US20080305089A1 (en) 2008-12-11
US9950017B2 (en) 2018-04-24
EP1964570A1 (de) 2008-09-03
EP1964570B1 (de) 2012-11-21

Similar Documents

Publication Publication Date Title
DK1964570T3 (da) Farmaceutisk sammensætning til beskyttelse mod allergier og inflammatoriske sygdomme
LTC2140867I2 (lt) Farmacinė kompozicija
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK3345625T3 (da) Farmaceutisk sammensætning og indgivelser deraf
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0715712A2 (pt) Composição farmacêutica
DK2222675T3 (da) 5-anilinoimidazopyridiner og fremgangsmåder til deres anvendelse
DK2142220T3 (da) Lerbaserede hæmostatiske midler og anordninger til tilførsel heraf
DK1984338T3 (da) Pyridylphenylforbindelser til inflammations- og immunrelaterede anvendelser
DK1991678T4 (da) Sammensætninger og fremgangsmåder til oligonukleotid-formuleringer
DK3263589T5 (da) Peptidsekvenser og sammensætninger
DK3492069T3 (da) Farmaceutiske sammensætninger omfattende jern-oxy-hydroxid
DK2154966T3 (da) Benzimidazoler og farmaceutiske sammensætninger deraf
BRPI0820381A2 (pt) Formulações farmacêuticas
BRPI0719393A2 (pt) Composição farmacêutica
DK2107905T3 (da) Fast sammensætning omfattende alogliptin og pioglitazon
BRPI0812562A2 (pt) composições terapêuticas anti-cd20 e métodos
DK2207773T3 (da) Heterocyklisk forbindelse og farmaceutisk sammensætning deraf.
DK2192933T3 (da) Materialer til oftalmologisk og ortorhinolaryngologisk anordning
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0716445A2 (pt) composiÇço farmacÊutica
DK2114393T3 (da) Farmaceutiske sammensætninger omfattende trigonellin og 4-hydroxyisoleucin og fremgangsmåde hertil
BRPI0720234A2 (pt) Composição farmacêutica
DK2805746T3 (da) Alkylamido-forbindelser og anvendelser deraf
DK2001556T3 (da) Thioninium-forbindelser og anvendelse deraf